chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reported pain at injection site, achiness across chest and back and congestion starting about 1 week after vaccine. Comes and goes, but feels like it's getting better. Takes Ibuprofen to help.
Patient reports immediate onset of left arm pain after first vaccination.  It continued until a second vaccination which she got of the in the arm.  He states he continues to have intermittent pain especially when lifting the arm above his head.  No previous reported left arm pain or left shoulder injuries.
I woke up on  day 4 after shot and felt pain in my breast and lymph nodes. Same side as my cancer. Very disturbing. I had a horrible reaction, high fever 2 days. Splitting headache. Nausea. Body aches.  I was not aware that lymph nodes could be a reaction and it scared me. Thought my cancer might have come back.
day of vaccine and one day after, patient felt warm/feverish, muscle cramping, very fatigued/could not get around alone. day 3 patient is feeling better
Information has been received from a physician concerning a male patient that "15 years ago had a wild type measles" who on an unspecified date after  that illness, was vaccinated with a dose of MMR II. Physician stated that 24 hours after received the MMR II the patient became deaf. It was unspecified if lab tests were performed. The patient's outcome was unspecified. Deaf was considered to be disabling. This is one of several reports received from the same source. No further information is available.
feel off; balance was a little off/a little drifty; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feel off) and BALANCE DISORDER (balance was a little off/a little drifty) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jun-2021, the patient experienced FEELING ABNORMAL (feel off) and BALANCE DISORDER (balance was a little off/a little drifty). At the time of the report, FEELING ABNORMAL (feel off) and BALANCE DISORDER (balance was a little off/a little drifty) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment information was provided.  The next day after receiving the first dose of the vaccine he started to feel off. This was like his balance was a little off. It got better after a couple of weeks, but never completely resolved. He continued to feel a little drifty.   This case was linked to MOD-2021-369161 (Patient Link).
09/29/2019 in the evening the child had a 15 minute seizure like activity at home, went to Med Center had negative labs and head CT. Evening of 09/30/2019 seizure like activity again. 10/01/19 went to another Hospital, now on Kepra and scheduled for EEG and MRI.
Generalized myalgia during the night after vaccination Injection site muscle pain for 36 hrs Generalized pruritus and urticaria/raised red rash after scratching, starting 24 hrs after vaccination
10:15 C/O chest pain after vaccine (H1N1) also C/O dizziness. Reports "always has chest pains after shots". Did not report this info to nurse @ time of vaccination. Ate breakfast, with fluids, lungs clear to auscultation----. Reclined to floor - sprite offered po. Encouraged to do paused breathing. Rested x 15 minutes. Student sat upright - reported Sx's decreased to return to class. Returned to class with instruction to see school nurse if Sx's reoccur.
Upper left arm is red and itchy.  I don?t know if this is related to the vaccination since it began 10 days after vaccination, but I thought I should report it. I had no immediate adverse event following the vaccination except a sore arm for two days.
Sore arm; Headache; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K202A and 028L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 19-Nov-2020. Concomitant products included THYROID (ARMOUR THYROID) and LIOTHYRONINE SODIUM (CYTOMEL) for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache). The patient was treated with ONDANSETRON (ZOFRAN MELT) at an unspecified dose and frequency; PARACETAMOL (TYLENOL EXTRA-STRENGTH) at an unspecified dose and frequency and LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN D 12 HOUR) at an unspecified dose and frequency. On 08-Jan-2021, PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details included zofran, ginger, extra strength tylenol, Claritin D,.  Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-029213.
pt recv vax 17OCT95 & 30AUG96 pt devel 50-100 lesions, described as classic chicken pox;
fifty cent sized rash around the injection site, medium itching for 3-4 days, controlled with an antihistamine gel.
pt to clinic on 2NOV95 @ 10:15 for nurse to check inj site;rt deltoid&upper arm w/erythema&edema;hot to touch;hard area w/2inch band extended from back arm to front arm;inc T;edema & erythema to ax of arm w/poss/?gland involvement;dizzy
AFTER ABOUT 3 MINUTES AFTER THE LAST IMZ- MODERNA-B BOOSTER THE PATIENT SAID HE WAS HAVING A REACTION, HE SAID HE WAS LIGHT HEADED, GONGESTED, PAIN IN BACK FLUSH AND CLAMY. HE SAT AND WE GAVE HIM WATER, AND A COOL RAG. HE STARTED FEELING BETTER AND GAVE HIM A LOLLYPOP JUST IN CASE HIS BLOOD SUGAR WAS LOW. HE FELT BETTER AND WAS ABLE TO LEAVE WITH HIS WIFE
Headache after shot was administered. At 0400 began having chills, body aches, redness and itching around injection site, nausea, sore throat, ear ache. Took Excedrin migraine. Symptoms have resolved.
Information regarding Dryvax (smallpox vaccine dried calf lymph type injection) was received from the mother in law of a 26 year old male pt who received a dose in 2003, and developed myocarditis, pericarditis, increased blood pressure, kidney problems and lost 35 pounds over one year. No medical history per reporter. Indication for Dryvax was immunization. Product was administered in 2003. Dose regimen was 1 dose. Pt was not taking concomitant therapy. In 2003, while in Iraq for active military duty, the pt received a dose of Dryvax and 3 days post vaccination, had severe chest pain and was admitted to the intensive care unit for approx 5 days. The pt was diagnosed with myocarditis and pericarditis in 2003, and was transferred. The reporter also stated that pt developed increased blood pressure, kidney problems (renal disorder) and lost 35 pounds over one year indicating his current weight to be 175 pounds. The reporter also stated the pt was treated and prescribed multiple medications, which were unk. The pt's recovery status is UNK. No additional information was available at the time of this report.
(3/19/2021) 1 day after first dose of vaccine, all fingers on both hands turned red from the knuckle to the tips. Fingers were very hot and itchy. Effect lasted 2-5 min.  (3/20/2021) 2 days after first does of vaccine, hands and legs turned red and itchy for 2 hours. Took Benadryl to calm itching.
Fever, RespDepression & COVID positive REMDESIVIR (EUA) 200 mg x1 then 100 mg daily
Pt had erythema and swelling after flu shot, starting about 36 hours later; she had the same reaction last year and was treated for cellulitis; however, today it appears to be an immune response and not cellulitis
I received the bivalent covid booster on 10/12/22 at the local medical center..   12-18 hrs post vaccine, I began to have common side effects: chills, low grade fever, pain at injection site, for which I took ibuprofen. 36-48 I had swelling, redness and pain at the injection site and red, hot and swollen, painful axillary lymph nodes, for which I took ibuprofen and iced my arm 72hrs-lymph nodes are better but injection site is red, hot, and swollen to the size of a softball.    Today at 72 hours post vaccine, I went to see Specialists in employee health regarding my symptoms. One specialist gave me an ice pack, reassured me to continue taking ibuprofen, and instructed me to contact you with this information.
This case was reported by a other health professional via call center representative and described the occurrence of shingles in a 71-year-old male patient who received SHINGRIX (batch number 9779K, expiry date 11th October 2020) for prophylaxis. Concurrent medical conditions included blood pressure high, diabetes, asthma, allergic rhinitis, chronic obstructive pulmonary disease, gastroesophageal reflux disease, cerebrovascular accident, coronary artery disease, carotid artery stenosis and drug allergy (erythromycin). Concomitant products included fluticasone propionate, salmeterol xinafoate (Advair Diskus), fluticasone propionate (Flonase), gabapentin (Neurontin), isosorbide mononitrate (Imdur), salbutamol sulphate (Albuterol), acetylsalicylic acid (Aspirin), atorvastatin calcium (Atorvastatin), folic acid, metformin hydrochloride (Metformin), omeprazole, glimepiride (Amaryl), ticagrelor (Brilinta), tadalafil (Cialis), pregabalin (Lyrica), lisinopril and metoprolol. On 21st May 2018, the patient received the 1st dose of SHINGRIX (intramuscular). In May 2018, 7 days after receiving SHINGRIX, the patient experienced shingles, rash, nerve pain and burning sensation. The patient was treated with valaciclovir hydrochloride (Valtrex) and lidocaine hydrochloride (Lidocream). On an unknown date, the outcome of the shingles, rash, nerve pain and burning sensation were unknown.  It was unknown if the reporter considered the shingles, rash, nerve pain and burning sensation to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX on left deltoid. One week after receiving first dose of SHINGRIX, the patient experienced rash on the right side of his face, around his forehead and eyes. There was also burning and nerve pain at the site. The patient went to an eye doctor, and also had two doctor visits. The patient was prescribed Valtrex and Lidocream for symptoms, and was also diagnosed with shingles. On 21st May 2018 and 5th July 2018, the patient visited doctor. The reporting MA (medical assistant) stated the that patient's physician believes the symptoms are related to SHINGRIX.
Possible flare of RA. Symptons include fatigue, pain  and stiffness in joints; parficularly right shoulder.
This spontaneous report was received from a 86 year old female patient concerning herself. Information regarding concomitant medication, medical history and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (route, strength, dosage schedule, lot # and expiration date were not reported). On an unknown date, the patient experienced herpes zoster (reported as "shingles", generalized pain and pruritus (reported as "my body still itches and hurts"). There was no product quality complaint (PQC) involved. At the reporting time, the patient did not recover from the herpes zoster, generalized pain and pruritus. The reporter did not assessed causality between the events and the use of ZOSTAVAX. Additional information is not expected as the reported denied consent to contact the physician.
Left shoulder not able to rotate. Painful to lay on. Left arm progressively worse since flu shot. No shoulder joint swelling per MD (per pt). Pt was seen at urgent care 12-14-17. No report of falling or injury to shoulder per pt. Pt given hydrocodone/APAP and ibuprofen.
Information has been received from a physician concerning his 70 year old Asian wife who on 6/14/02 at 8:50am was vaccinated SC in the left upper arm with 0.5mL of pneumococcal vaccine 23 polyvalent (lot 641130/1161L). The physician reported that he gave his wife a dose of pneumococcal vaccine 23 polyvalent. He reported that she had a dose more than 5 or 6 years ago. On 6/14/02 after receiving the vaccine, the pt experienced swelling that started at the injection site and continued all the way down her arm. The physician reported that he gave his wife a few doses of prednisone and antihistamine and the swelling went down. The physician also reported that he had a slight reaction at the injection site after he vaccinated himself in the thigh with pneumococcal vaccine 23 polyvalent (lot 641130/1161L) (WAES0210USA01097). Additional info has been received from the physician. The physician reported that on 6/14/02 at 11:20am his wife developed swelling and redness at the injection site in her left upper arm which extended to her hand and fingers of the same arm. The pt was seen in her physician's office. She was treated with a cold compress to the injection site and oral prednisone (initial dose 60mg daily then 50mg daily, 40mg daily, 30mg daily, 20mg daily, 10mg daily and then stopped after a total of 6 days). The physician reported that his wife recovered. The reporting physician considered the injection site swelling, injection site erythema and peripheral swelling to be other important medical events (OMIC). No additional info is expected.
Moderna Covid-19 vaccine which has undergone multiple temperature excursions.  Twenty six  patients received the vaccine in question.; Moderna Covid-19 vaccine which has undergone multiple temperature excursions.  Twenty six  patients received the vaccine in question.; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna Covid-19 vaccine which has undergone multiple temperature excursions.  Twenty six  patients received the vaccine in question.) and EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine which has undergone multiple temperature excursions.  Twenty six  patients received the vaccine in question.) in a 56-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 15-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine which has undergone multiple temperature excursions.  Twenty six  patients received the vaccine in question.). In March 2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna Covid-19 vaccine which has undergone multiple temperature excursions.  Twenty six  patients received the vaccine in question.). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna Covid-19 vaccine which has undergone multiple temperature excursions.  Twenty six  patients received the vaccine in question.) and EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine which has undergone multiple temperature excursions.  Twenty six  patients received the vaccine in question.) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported. The Nurse reports no adverse reactions or side effects to the Moderna Covid-19 vaccine. The temperature excursions occurred on 4-mar-2022, 5-mar-2022, 7-mar-2022, 8-mar-2022,9-mar-2022, and 10-mar-2022.
?Abnormal feeling? to his lateral, right upper and lower eyelids, and around the region of his right cheek bone, which he can best describe as tingling. He reports he has not had any symptoms to the right eye, itself. He states he has some mild facial drooping involving his right upper eyelid and his right cheek. He reports mild swelling under his right eye, as well as to his right cheek area. He also reports that he can?t fully open his right eye, which impairs his field of vision; otherwise, denies any vision changes. Instructed that the symptoms were suggestive of Bell?s Palsy, but to go straight to ER for further evaluation.
Large (6 inches x 4 inches) oval area at injection site became raised/swollen, red, and itchy.  This finally resolved 7 days later.  Treatment included taking Benadryl a few times subsequent to the reaction, and applying Cortizone 10 Creme with Aloe several times a day to relieve itching.
This case was reported by a physician via a GSK representative, and described the occurrence of cellulitis in a child female subject of appropriate age who was vaccinated with KINRIX (GlaxoSmithKline). Concomitant vaccines, medications and relevant medical history were unknown. It was not known whether the subject had experienced adverse events following previous vaccinations. On 17 July 2009 the subject received unspecified dose of KINRIX (details unknown). On 17 July 2009, less than one day after vaccination with KINRIX, the subject experienced injection site redness and swelling at injection site. The subject was seen at the Emergency Room and diagnosed with cellulitis. The physician reported that it was the "largest local reaction he has ever seen". This case was assessed as medically serious by GSK. The subject was treated with antibiotics (Antibiotic) from the Emergency Room. Upon return to the physician office for follow up, the physician added another antibiotic, but noted that the subject did not have a fever and was "acting normal". At the time of reporting the outcome of the events was unspecified. The physician considered the events were possibly related to vaccination with KINRIX.
PATIENT HAD A FEVER FOR 3 DAYS, BROKE OUT WITH CHICKEN POX; FOURTH DAY OK; ON FIFTH DAY, HIVES ALL OVER THE BODY WITH ITCHING. ITCHING WAS STILL PRESENT WHEN REPORTED TO ME AT 6-21-21
Tinnitus, headache and slight dizziness. This is still occurring 3 weeks after the first vaccine.
no other ae reported; stored outside of the recommended storage range; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 22-SEP-2020, the patient was vaccinated with improperly stored doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, recombinant human albumin (rHA) (lot # s020961, expiration date 07-JUL-2021), 1 dose and with varicella virus vaccine live (oka/merck)(VARIVAX) (lot# t010310, expiration date 24-MAR-2022), 1 dose both (strength, frequency, route of administration were not reported for both) each for prophylaxis. No adverse effects were reported. According to the reporter, the temperature excursion was 19.32 degrees Celsius for a time frame of 7 hours and 45 minutes on an unspecified date, without any previous temperature excursion; which was not detected by a digital data logger.
pt recv vax & 19JAN89 pt exp partial paralysis;the reporter had no indication of the exp in pt chart;pt was not seen again until 15FEB89 @ which time pt still did not mention limping or paralysis;@ that time, pt had a bruise on leg;
Rash on (R) arm at injection site. Redness, hot to touch, red streak to inside of arm.
This 86 year old woman was given a Zostavax on 10/06/2006. On 11/02/2006 she developed herpes zoster of the first division of the fifth cranial nerve, fortunately without eye involvement. (OMIC) She did have an episode of zoster - not due to flu vaccine & did better than expected due to the vaccine
Fever of 102.3F, pulse 160, occasional wheezing. Was given acetaminophen suppositories 80mg every 4 hours. Exam at ER on same day, was normal; exam on the next day, child was febrile, otitis, tonsillitis, fine papular erythematous rash on back.
WAS TESTED FOR PRE-ADMISSION TESTING 5/21/21  AND TESTED POSITIVE. PATIENT IS ASYMPTOMATIC
Erythema, swelling and itching overlying injection site, well circumscribed location started 8 days following vaccination, stable, patient instructed to take Benadryl for itching . ER precautions discussed
Patient received Bivalent booster instead of a Pfizer 2nd dose. Patient stated to employee that he received 2 doses previously but there's only one dose in WIR.
Second dose: Had ringing in the ears; Second dose: Received second dose vaccine on left side, left knee replacement has been bothering; Second dose: Has face and neck acne; Second dose: Vomiting; Second dose: Diarrhea; Allergies; Second dose: On 01Oct2021, was extremely sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.   A 59 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Sep2021 (Lot number: FC3181) at the age of 59 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "knee replacement" (unspecified if ongoing), notes: had knee replacement in both knees; "Hysterectomy" (unspecified if ongoing), notes: complete hysterectomy prior to Pfizer Covid Vaccine; "allergies" (unspecified if ongoing), notes: just typical allergies for this time of year, fall and waking up. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose number: 1, route of administration: upper left arm), administration date: 26Aug2021, when the patient was 59 years old, for covid-19 immunization, reaction(s): "rash on lower torso and legs", "perfuse sweating and body odor". The following information was reported: TINNITUS (non-serious), outcome "not recovered", described as "Second dose: Had ringing in the ears"; ARTHRALGIA (non-serious), outcome "not recovered", described as "Second dose: Received second dose vaccine on left side, left knee replacement has been bothering"; ACNE (non-serious), outcome "unknown", described as "Second dose: Has face and neck acne"; ILLNESS (non-serious) with onset 01Oct2021, outcome "recovered" (08Oct2021), described as "Second dose: On 01Oct2021, was extremely sick"; VOMITING (non-serious), outcome "recovered" (Oct2021), described as "Second dose: Vomiting"; DIARRHOEA (non-serious), outcome "recovered" (Oct2021), described as "Second dose: Diarrhea"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "Allergies".  Additional information: Reporter states she had knee replacement in both knees: The caller clarifies both knee replacements occurred prior to receiving any dose Pfizer Covid Vaccine.  reporter says, I'm sorry, my allergies: Agent asks if the allergies began prior to receiving any dose Pfizer Covid Vaccine or after and the caller replies, no, just typical allergies for this time of year, fall and waking up. On 01Oct2021, the reporter was extremely sick, was vomiting and had diarrhea and all that. The reporter doesn't think this was from the Pfizer Covid Vaccine occurring that later after receiving the Pfizer Covid Vaccine. The reporter went to the urgent care that weekend and the following week, maybe 08Oct2021 it went away. The reporter clarifies the vomiting and diarrhea subsided a couple days after began, but the reporter was not herself.  Follow-up attempts completed. No further information expected.